- Home
- IPXX vs ANGO Comparison
IPXX vs ANGO Comparison
Compare IPXX & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPXX
- ANGO
- Stock Information
- Founded
- IPXX 2023
- ANGO 1988
- Country
- IPXX United States
- ANGO United States
- Employees
- IPXX N/A
- ANGO N/A
- Industry
- IPXX Blank Checks
- ANGO Medical/Dental Instruments
- Sector
- IPXX Finance
- ANGO Health Care
- Exchange
- IPXX Nasdaq
- ANGO Nasdaq
- Market Cap
- IPXX 337.5M
- ANGO 279.1M
- IPO Year
- IPXX 2023
- ANGO 2004
- Fundamental
- Price
- IPXX $10.99
- ANGO $8.86
- Analyst Decision
- IPXX
- ANGO Strong Buy
- Analyst Count
- IPXX 0
- ANGO 4
- Target Price
- IPXX N/A
- ANGO $12.00
- AVG Volume (30 Days)
- IPXX 14.0K
- ANGO 615.8K
- Earning Date
- IPXX 01-01-0001
- ANGO 01-08-2025
- Dividend Yield
- IPXX N/A
- ANGO N/A
- EPS Growth
- IPXX N/A
- ANGO N/A
- EPS
- IPXX 0.37
- ANGO N/A
- Revenue
- IPXX N/A
- ANGO $292,726,000.00
- Revenue This Year
- IPXX N/A
- ANGO N/A
- Revenue Next Year
- IPXX N/A
- ANGO $7.69
- P/E Ratio
- IPXX $29.42
- ANGO N/A
- Revenue Growth
- IPXX N/A
- ANGO N/A
- 52 Week Low
- IPXX $10.31
- ANGO $5.26
- 52 Week High
- IPXX $15.18
- ANGO $9.58
- Technical
- Relative Strength Index (RSI)
- IPXX 44.61
- ANGO 61.62
- Support Level
- IPXX $10.76
- ANGO $8.45
- Resistance Level
- IPXX $15.18
- ANGO $9.58
- Average True Range (ATR)
- IPXX 0.86
- ANGO 0.49
- MACD
- IPXX -0.16
- ANGO 0.05
- Stochastic Oscillator
- IPXX 5.23
- ANGO 65.79
About IPXX Inflection Point Acquisition Corp. II
Inflection Point Acquisition Corp II is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.